What's New

The Lived Experience of FTD: The Challenges of July Fourth

The following article was written by former Persons with FTD Advisory Council member Cindy Odell. The Council works to ensure the voice of people living with FTD guides AFTD as…

Read More about The Lived Experience of FTD: The Challenges of July Fourth

Chinese Study Explores the Psychological Well-being and Health of Dementia Caregivers

A study published in the journal BMC Geriatrics explores the self-assessed well-being of informal care partners and professional caregivers who support people with dementia, such as FTD. The study provides…

Read More about Chinese Study Explores the Psychological Well-being and Health of Dementia Caregivers

“Alzheimer’s & Dementia” Publishes Summary of AFTD’s 2022 Holloway Summit

Digital health technologies have the potential to benefit the FTD community by improving accessibility to research and clinical care. Such technologies were the focus of the 2022 Holloway Summit —…

Read More about “Alzheimer’s & Dementia” Publishes Summary of AFTD’s 2022 Holloway Summit

Leonard A. Lauder, 1933-2025

Leonard A. Lauder, a legend of the cosmetics industry who invested hundreds of millions of dollars into research seeking a cure for FTD and other dementias through his Alzheimer’s Drug…

Read More about Leonard A. Lauder, 1933-2025

Vesper Bio Clinical Trial for FTD-GRN Treatment Achieves Enrollment Milestone

Danish biotechnology company Vesper Bio announced that it reached a participation milestone in its phase Ib/IIa clinical trial evaluating a treatment for FTD-GRN. Six participants have been enrolled in the…

Read More about Vesper Bio Clinical Trial for FTD-GRN Treatment Achieves Enrollment Milestone

Advancing Hope: Blood Test for Diagnosing Alzheimer’s Disease Approved by FDA

The United States Food and Drug Administration (FDA) approved the marketing of a blood test to diagnose Alzheimer’s disease. The test, known as the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma…

Read More about Advancing Hope: Blood Test for Diagnosing Alzheimer’s Disease Approved by FDA

British Study Evaluates Ability of Novel Protein Assay to Capture Blood-Based Dementia Biomarkers

A study published in the journal Alzheimer’s & Dementia evaluates the ability of a novel protein assay to detect and analyze blood-based biomarkers of dementias, including FTD. Blood Biomarkers as…

Read More about British Study Evaluates Ability of Novel Protein Assay to Capture Blood-Based Dementia Biomarkers

Former U.S. Rep. Wexton, Living with PSP, Featured in “Brain & Life” Magazine 

Jennifer Wexton, a former member of Congress who stepped down after revealing her progressive supranuclear palsy (PSP) diagnosis, was featured on the cover of the April/May issue of Brain &…

Read More about Former U.S. Rep. Wexton, Living with PSP, Featured in “Brain & Life” Magazine 

Dear HelpLine: The GUIDE Model and FTD

Dear HelpLine, My neurologist’s office recently told me about something called GUIDE, for people with dementia. I’m wondering if this program could help with FTD. Where can I learn more? …

Read More about Dear HelpLine: The GUIDE Model and FTD

Genetic FTD Advocate Linde Jacobs Profiled in CBS Minnesota Segment

Linde Jacobs, a Minnesota nurse who has devoted herself to genetic-FTD advocacy after learning that she and her sisters share the same MAPT mutation that caused her mother’s FTD, was…

Read More about Genetic FTD Advocate Linde Jacobs Profiled in CBS Minnesota Segment